These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21346143)

  • 1. FOXQ1 regulates epithelial-mesenchymal transition in human cancers.
    Qiao Y; Jiang X; Lee ST; Karuturi RK; Hooi SC; Yu Q
    Cancer Res; 2011 Apr; 71(8):3076-86. PubMed ID: 21346143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A; Kim SH; Vogt A; Singh SV
    Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
    Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
    Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
    Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
    FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
    Feng J; Xu L; Ni S; Gu J; Zhu H; Wang H; Zhang S; Zhang W; Huang J
    Oncotarget; 2014 Oct; 5(20):9689-702. PubMed ID: 25356753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead factor FOXQ1 promotes TGF-β1 expression and induces epithelial-mesenchymal transition.
    Fan DM; Feng XS; Qi PW; Chen YW
    Mol Cell Biochem; 2014 Dec; 397(1-2):179-86. PubMed ID: 25287361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
    Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
    Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
    Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
    Xiao B; Liu H; Gu Z; Ji C
    Arch Bronconeumol; 2016 Oct; 52(10):505-11. PubMed ID: 26858166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
    Kim SH; Hahm ER; Singh KB; Singh SV
    Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.
    Meng F; Speyer CL; Zhang B; Zhao Y; Chen W; Gorski DH; Miller FR; Wu G
    Cancer Res; 2015 Feb; 75(3):584-93. PubMed ID: 25502837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the role of FOXQ1 in colorectal cancer metastasis.
    Abba M; Patil N; Rasheed K; Nelson LD; Mudduluru G; Leupold JH; Allgayer H
    Mol Cancer Res; 2013 Sep; 11(9):1017-28. PubMed ID: 23723077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
    Guo J; Yan Y; Yan Y; Guo Q; Zhang M; Zhang J; Goltzman D
    Oncol Rep; 2017 Oct; 38(4):2003-2010. PubMed ID: 28791370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis.
    Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
    Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.